WALTHAM, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) (“the Company”) today provided an update on injection kits supplied by Apellis and an update on the rare ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Apellis is exclusively distributing injection kits with ...
Apellis Pharmaceuticals, a biotech drug company based in Waltham, Mass., recalled more than 61,000 injection needle kits after eight retinal vasculitis cases were reported. The company is pulling 12 ...
Support to the market growth comes from shift towards increased safety standards & compliance with more stringent regulatory requirements. Healthcare practitioners are rapidly incorporating filter ...
Credit: Apellis. Syfovre is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration. Apellis announced that as part of its investigation into real-world safety ...
Report Ocean has published a new report on the Filter Needles Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...
More than 100,000 vials have been distributed/administered between real world and clinical trials; since last update, confirmed one additional event of retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback